Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

SIMPLE SUMMARY: Glioblastoma (GB) is an aggressive brain tumour with poor survival. Tumour microenvironment is a key element in GB evolution and response to therapy. We assessed presence and phenotypes of microglia/macrophages in preclinical GL261-GB microenvironment under Temozolomide (TMZ) treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Calero-Pérez, Pilar, Wu, Shuang, Arús, Carles, Candiota, Ana Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199490/
https://www.ncbi.nlm.nih.gov/pubmed/34071393
http://dx.doi.org/10.3390/cancers13112663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199490/
https://www.ncbi.nlm.nih.gov/pubmed/34071393
http://dx.doi.org/10.3390/cancers13112663

Ejemplares similares